Next Article in Journal
Goal Orientation and Physical Activity: Psychometric Properties of the Polish Version of the Goal Orientation in Exercise Measure (GOEM)
Next Article in Special Issue
Immunotherapy for Peritoneal Metastases from Gastric Cancer: Rationale, Current Practice and Ongoing Trials
Previous Article in Journal
Patients with Moyamoya Vasculopathy Evaluated at a Single-Center in The Netherlands; Clinical Presentation and Outcome
Editorial

Prevention and Treatment of Peritoneal Metastases from Gastric Cancer

Washington (D.C.) Cancer Institute at Washington Hospital Center, Washington, DC 20007, USA
J. Clin. Med. 2021, 10(9), 1899; https://doi.org/10.3390/jcm10091899
Received: 20 April 2021 / Accepted: 26 April 2021 / Published: 28 April 2021
(This article belongs to the Special Issue Advances in Peritoneal Carcinomatosis from Gastric Cancer)
Note: In lieu of an abstract, this is an excerpt from the first page.

Common knowledge would suggest that regional treatments for peritoneal metastases from gastric cancer would not be successful [...] View Full-Text
MDPI and ACS Style

Sugarbaker, P.H. Prevention and Treatment of Peritoneal Metastases from Gastric Cancer. J. Clin. Med. 2021, 10, 1899. https://doi.org/10.3390/jcm10091899

AMA Style

Sugarbaker PH. Prevention and Treatment of Peritoneal Metastases from Gastric Cancer. Journal of Clinical Medicine. 2021; 10(9):1899. https://doi.org/10.3390/jcm10091899

Chicago/Turabian Style

Sugarbaker, Paul H. 2021. "Prevention and Treatment of Peritoneal Metastases from Gastric Cancer" Journal of Clinical Medicine 10, no. 9: 1899. https://doi.org/10.3390/jcm10091899

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop